The Center for the Neuroscience of Psychedelics at Massachusetts General Hospital, was founded in April 2021 to advance neuroscientific knowledge of psychedelic drugs. Jerrold F. "Jerry" Rosenbaum, the Center Director, says he faced no opposition in starting the initiative.